PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1314698-4	1992	The antiproliferative effects of TNF on L-929 cells were inhibited by orthovanadate, an inhibitor of phosphotyrosine phosphatases, in a dose-dependent manner.	Vanadates	70-83	tumor necrosis factor	Mus musculus	33-36	
1314698-5	1992	Okadaic acid, which is a specific inhibitor of phosphoserine- and phosphothreonine-specific phosphatases, also blocked the growth-inhibitory effects of TNF, suggesting that TNF may function through the activation of certain phosphatases.	Okadaic Acid	0-12	tumor necrosis factor	Homo sapiens	152-155	
1314698-5	1992	Okadaic acid, which is a specific inhibitor of phosphoserine- and phosphothreonine-specific phosphatases, also blocked the growth-inhibitory effects of TNF, suggesting that TNF may function through the activation of certain phosphatases.	Okadaic Acid	0-12	tumor necrosis factor	Homo sapiens	173-176	
1314698-5	1992	Okadaic acid, which is a specific inhibitor of phosphoserine- and phosphothreonine-specific phosphatases, also blocked the growth-inhibitory effects of TNF, suggesting that TNF may function through the activation of certain phosphatases.	Phosphoserine	47-60	tumor necrosis factor	Homo sapiens	152-155	
1314698-5	1992	Okadaic acid, which is a specific inhibitor of phosphoserine- and phosphothreonine-specific phosphatases, also blocked the growth-inhibitory effects of TNF, suggesting that TNF may function through the activation of certain phosphatases.	Phosphoserine	47-60	tumor necrosis factor	Homo sapiens	173-176	
1314698-8	1992	Cells were protected by orthovanadate from the cytotoxic effects of TNF even in the presence of actinomycin D or cycloheximide, thus indicating the lack of a requirement for de novo protein synthesis.	Vanadates	24-37	tumor necrosis factor	Homo sapiens	68-71